User Reviews for Trametinib
Also known as: Mekinist
Trametinib has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of those users who reviewed Trametinib reported a positive effect, while 0% reported a negative effect.
| Condition | Avg. Rating | Reviews | Compare | |
|---|---|---|---|---|
| Melanoma, Metastatic | 9.0 | 1 reviews | 14 medications | |
| Summary of Trametinib reviews | 9.0 | 1 reviews | ||
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about trametinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: multikinase inhibitors
Consumer resources
Other brands: Mekinist
Mekinist (trametinib) for Melanoma, Metastatic: “Have been on Mekinist and Dabrafenib for 2 weeks only. So far melanomas have reduced in size. Blood test results were good. Hoping it continues but I must stress it is only early days for me. Two combined drugs are working as they should. Some nausea, aching and itchiness. But taking antihistamines. Melanomas are in spine so pain expected.”